Imatinib plasma levels: correlation with clinical benefit in GIST patients. - Wikidata - awgldk - TriplyDB

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

http://www.wikidata.org/entity/Q42843116

about

Environmental and genetic factors affecting transport of imatinib by OATP1A2 Contribution of tumoral and host solute carriers to clinical drug response.Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors.Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): an emerging role for drug blood level testing?Therapeutic drug monitoring in cancer chemotherapy.Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets.Controversies in the management of gastrointestinal stromal tumors.Therapeutic drug monitoring of targeted anticancer therapy.Clinical benefit of sunitinib in gastrointestinal stromal tumors with different exon 11 mutation genotypes.Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels.Pharmacokinetic-Guided Dosing of New Oral Cancer Agents.Imatinib Pharmacokinetics in a Large Observational Cohort of Gastrointestinal Stromal Tumour Patients.How 'Optimal' are Optimal Sampling Times for Tyrosine Kinase Inhibitors in Cancer? Practical Considerations.

P2860

Q33878471-F6FDD083-5933-4148-A22B-40D4E637C655 Q35946876-5F4FE7D9-C1D8-4CE0-B933-C46C9B574A06 Q36180074-B1545B7B-0504-4171-817C-8CB481979EC1 Q37731289-5ED6D958-FE57-46BB-9DC7-19728CC3FE39 Q37810220-04EE9385-FD5B-4D91-8B90-53CC14097A49 Q38190857-838AD23E-BB6A-47C5-9B5B-B946E16CE508 Q38199797-C6F5B495-EFC7-4E16-9847-06AF3FFCBF96 Q38579278-05D19573-ED25-4DBA-90DF-CE7BC115C420 Q38661495-8E4307E0-74CC-403A-BC5F-C75077B41765 Q39429946-065BA1D4-AD5F-4A7B-902E-E66E1B061B21 Q39651800-7D892109-A0D1-4E42-BD12-8DE88D4DF099 Q47969048-4511771D-CC59-4CCB-B108-7B17B7695A65 Q48152547-F6BEC715-769E-4FF0-862E-217853D1E70D Q48826707-BDEF6CAF-4F34-48BF-93B4-CF7410E1CCD9

P2860

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

http://www.wikidata.org/entity/Q42843116

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

@en

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

@nl

type

label

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

@en

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

@nl

prefLabel

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

@en

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

@nl

P1433

Q42843116-396BDC9B-F77F-476C-B509-0010A829E68A

P1476

Q42843116-47675C8A-CB83-4902-BA61-4A73D9D72E15

P2093

Q42843116-113D43F7-3BC8-4A8E-9F8D-1D0A29953700

Q42843116-89E723B6-7B9C-40F2-945A-10176E19A63D

Q42843116-9DD9B804-01CD-4699-9079-B4DBA7EA8596

Q42843116-DBFDCD21-526A-4114-A9B9-FB39832410A2

P2860

Q42843116-63FF9F97-A6BC-4EA4-8F4A-CC807ABA8C4C

Q42843116-68E82327-7CB3-464A-B876-577B499F3A52

Q42843116-6D15D299-7D50-47A3-9951-D84B6C2B9829

Q42843116-88790E52-D448-46D1-9971-5E95EDD8ED74

Q42843116-A72849AF-9094-4583-9F20-449BE9E01026

Q42843116-AE0AC01D-4A3F-43A4-8929-DB8B5C5AF357

Q42843116-BC613BB4-D39A-4A97-9D1E-54FDE2F1D0B0

Q42843116-C16404DD-F176-4507-B0E0-A1108CCA3BD9

Q42843116-EED9D0A9-FCFF-4432-83E9-9B41EE11DD74

P2888

Q42843116-930ED903-C6F7-4BE9-8DD5-DE237A2857B0

P304

Q42843116-5F7018D7-BE5A-4AD8-89F2-18731442D8BE

P31

Q42843116-D0EB1075-ED26-4F89-92B3-3B3C049CE6E3

P356

Q42843116-24C210AA-160C-4654-AC20-ADD563C74426

P407

Q42843116-FC59AF5F-CCDB-4346-94DC-4E92BAFFCBC7

P433

Q42843116-FAE6A854-27C6-460C-8B2A-107635119278

P478

Q42843116-7F4D3D7C-BFC2-4272-B2B1-C42775C3D3D5

P50

Q42843116-48F41FEC-2911-4A01-B028-DB9D3D5862A0

Q42843116-5F53DE9E-77A7-4928-A7B9-2BB3381D34CC

Q42843116-D710182E-BC48-4481-92C9-89C13C1FDF6D

P577

Q42843116-BF8AE7E6-A7E1-4F72-8204-1BC8399D2888

P5875

Q42843116-580407AB-C754-42DF-84DD-9D9272CB9BE0

P698

Q42843116-7B07C460-8BCC-4A8A-A909-DD989E83D27D

P932

Q42843116-40F6A9F1-D473-4803-BFD3-76E0798F5D99

P356

P1433

British Journal of Cancer

P1476

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

@en

P2093

A Haouala

http://www.w3.org/2001/XMLSchema#string

L A Decosterd

http://www.w3.org/2001/XMLSchema#string

M Montemurro

http://www.w3.org/2001/XMLSchema#string

S Leyvraz

http://www.w3.org/2001/XMLSchema#string

P2860

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein.

Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability.

Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group.

Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.

Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors.

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study.

Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors

Therapeutic drug monitoring in CML patients on imatinib

P2888

P304

1198-1199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605584

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41548760

http://www.w3.org/2001/XMLSchema#string

P698

20179709

http://www.w3.org/2001/XMLSchema#string

P932

2853086

http://www.w3.org/2001/XMLSchema#string